Bactol, Bea Claudine P.
HRN: 22-48-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2023
CEFUROXIME 500MG (TAB)
02/22/2023
03/01/2023
ORAL
500mg
Q12
UTI; T/C Endometritis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes